Cleared Traditional

K183426 - MectaLIF Anterior Stand Alone Extension

K183426 is the FDA 510(k) clearance for MectaLIF Anterior Stand Alone Extension by Medacta International S.A.. It is a Class 2 Orthopedic device (product code OVD) cleared through the Traditional 510(k) pathway after a 94-day FDA review.

K183426 · Medacta International S.A. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
94d
Days
Class 2
Risk

K183426 is an FDA 510(k) clearance for the MectaLIF Anterior Stand Alone Extension. Classified as Intervertebral Fusion Device With Integrated Fixation, Lumbar (product code OVD), Class II - Special Controls.

Submitted by Medacta International S.A. (Castel San Pietro (Ch), CH). The FDA issued a Cleared decision on March 15, 2019 after a review of 94 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Medacta International S.A. devices

Submission Details

510(k) Number K183426 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 11, 2018
Decision Date March 15, 2019
Days to Decision 94 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d faster than avg
Panel avg: 122d · This submission: 94d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OVD Intervertebral Fusion Device With Integrated Fixation, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Lumbar Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Medacta USA
Chris Lussier

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OVD Intervertebral Fusion Device With Integrated Fixation, Lumbar

All 147
Devices cleared under the same product code (OVD) and FDA review panel - the closest regulatory comparables to K183426.
Idys ALIF TiVac
K191263 · Clariance, Sas · Jun 2019
Juliet® Ti LL Lumbar Interbody Device
K190877 · Spineart · May 2019
Rampart One Lumbar Interbody Fusion System
K191091 · Spineology, Inc. · May 2019
Avenue P Cage System
K181096 · Zimmer Biomet Spine, Inc. · Jan 2019
Reliance Lumbar IBF System
K181118 · Reliance Medical Systems · Jan 2019
Renovis Tesera C/Tesera SC Anterior Cervical Fusion (ACF) System
K182007 · Renovis Surgical Technologies · Dec 2018